Clinical Trial: National Wilm's Tumor Study Late Effects
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: National Wilm's Tumor Study Late Effects
Brief Summary: The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.
Detailed Summary: The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Although most people in this study enjoy good health, some may be at risk for certain health conditions. We are collecting information from as many participants as possible in order to determine if they or their offspring are at risk for adverse medical conditions. If there is more than one case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate heritability and recurrence risks.
Sponsor: Emory University
Current Primary Outcome: To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions. [ Time Frame: 1 year after closure of study ]
Original Primary Outcome:
- To determine if participant's offsprings are at risk for adverse medical conditions.
- To answer questions about long-term effects of treatment for Wilm's tumors.
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Emory University
Dates:
Date Received: September 27, 2005
Date Started: September 2005
Date Completion: December 2011
Last Updated: November 23, 2013
Last Verified: November 2013
